Carcinoma, Merkel Cell - 24 Studies Found

Recruiting : QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
:
  • Stage IIIB Merkel Cell Carcinoma
  • Stage IV : 2015-06-03
    : Biological: aNK (NK-92) A natural killer cell line recovered from a patient with large granular lymphoma
Completed : S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
: Neuroendocrine Carcinoma of the Skin
: 1999-11-01
:
  • Drug: CMF regimen
  • Drug: cyclophosphamide
Active, not recruiting : Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma
:
  • Merkel Cell Carcinoma
  • Skin Cancer

: 2013-12-19
: Drug: Cabozantinib Cabozantinib 60 mg Oral Daily 28 days (4 weeks)
Completed : A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma
: Metastatic Melanoma and Merkel Cell Carcinoma
: 2012-07-12
:
  • Drug: Pasireotide sub-cutaneous formulation

Active, not recruiting : Merkel Positron Emission Tomography (PET) Protocol
: Merkel Cell Carcinoma
: 2009-11-12
:
  • Drug: Carboplatin

Recruiting : Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
:
  • Merkel Cell Carcinoma
  • Skin Cancer

: 2017-03-01
:
  • Drug: Nivolumab Nivolumab 240

Active, not recruiting : Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer
:
  • Recurrent Merkel Cell Carcinoma
  • Stage IIIA
  • Other: Laboratory Biomarker Analysis

Recruiting : Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
:
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma : 2015-10-21
    :
    • Drug: Avelumab Given IV

Completed : S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
:
  • Recurrent Neuroendocrine Carcinoma of the Skin
  • Stage II : 2003-09-10
    :
    • Drug: imatinib mesylate Given

Recruiting : A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
:
  • Melanoma
  • Merkel Cell Carcinoma
  • Drug: TALIMOGENE LAHERPAREPVEC (TVEC)
  • Radi
<<< Previous | Next >>>